Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells

Methods

Volumn 29, Issue 3, 2003, Pages 227-235

  Wang, Rong Fu ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Cancer vaccines; CD4+ T cells; cDNA library; Helper T peptides; Immunotherapy; Major histocompatibility complex class II; Targeting expression; Tumor antigens

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR ANTIGEN;

ACCURACY; ANALYTIC METHOD; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; COLUMN CHROMATOGRAPHY; DNA LIBRARY; DNA SCREENING; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HELPER CELL; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037368771     PISSN: 10462023     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-2023(02)00345-6     Document Type: Article

References (40)

1. Rosenberg S.A. Nature. 411:2001;380-384.
2. Houghton A.N., Gold J.S., Blachere N.E. Curr. Opin. Immunol. 13:2001;134-140.
3. Boon T., Cerottini J.-C., Van Den Eynde B., Van der Bruggen P., Van Pel A. Annu. Rev. Immunol. 12:1994;337-365.
4. Wang R.F., Rosenberg S.A. Immunol. Rev. 170:1999;85-100.
5. Morel P.A., Oriss T.B. Crit. Rev. Immunol. 18:1998;275-303.
6. Toes R.E., Ossendorp F., Offringa F., Melief C.J. Exp. Med. 189:1999;753-756.
7. Greenberg P.D. Adv. Immunol. 49:1991;281-355.
8. Rosenberg S.A.et al. Nat. Med. 4:1998;321-327.
9. Rock K.L., Goldberg A.L. Annu. Rev. Immunol. 17:1999;739-779.
10. Cresswell P. Annu. Rev. Immunol. 12:1994;259-293.
11. Germain R.N. Cell. 76:1994;287-299.
12. Cresswell P. Cell. 84:1996;505-507.
13. Roche P.A. Immunity. 3:1995;259-262.
14. Halder T.et al. Cancer Res. 57:1997;3238-3244.
15. Li K.et al. Cancer Immunol. Immunother. 47:1998;32-38.
16. Monach P.A., Meredith S.C., Siegel C.T., Schreiber H. Immunity. 2:1995;45-59.
17. Pieper R.et al. J. Exp. Med. 189:1999;757-766.
18. Sant A.J. Immunol. Res. 13:1994;253-267.
19. Sanderson S., Frauwirth K., Shastri N. Proc. Natl. Acad. Sci. USA. 92:1995;7217-7221.
20. Fujii S., Senju S., Chen Y.Z., Ando M., Matsushita S., Nishimura Y. Hum. Immunol. 59:1998;607-614.
21. Wang R.-F., Wang X., Atwood A.C., Topalian S.L., Rosenberg S.A. Science. 284:1999;1351-1354.
22. Wang R.-F., Wang X., Rosenberg S.A. J. Exp. Med. 189:1999;1659-1667.
23. Wang H.Y., Zhou J., Zhu K., Riker A.I., Marincola F.M., Wang R.-F. J. Exp. Med. 195:2002;1397-1406.
24. Sant A.J., Miller J. Curr. Opin. Immunol. 6:1994;57-63.
25. Wang R.F., Wang X., Johnston S.L., Zeng G., Robbins P.F., Rosenberg S.A. Cancer Res. 58:1998;3519-3525.
26. Southwood S.et al. J. Immunol. 160:1998;3363-3373.
27. Sturniolo T.et al. Nat. Biotechnol. 17:1999;555-561.
28. Zeng G., Touloukian C.E., Wang X., Restifo N.P., Rosenberg S.A., Wang R.F. J. Immunol. 165:2000;1153-1159.
29. Wang R.F., Parkhurst M.R., Kawakami Y., Robbins P.F., Rosenberg S.A. J. Exp. Med. 183:1996;1131-1140.
30. Skipper J.C.et al. J. Exp. Med. 183:1996;527-534.
31. Novak E.J., Liu A.W., Nepom G.T., Kwok W.W. J. Clin. Invest. 104:1999;R63-R67.
32. Kotzin B.L.et al. Proc. Natl. Acad. Sci. USA. 97:2000;291-296.
33. Sahin U., Tureci O., Pfreundschuh M. Curr. Opin. Immunol. 9:1997;709-716.
34. Old L.J., Chen Y.T. J. Exp. Med. 187:1998;1163-1167.
35. Chaux P.et al. J. Exp. Med. 189:1999;767-778.
36. Manici S.et al. J. Exp. Med. 189:1999;871-876.
37. Schultz E.S.et al. Cancer Res. 60:2000;6272-6275.
38. Jager E.et al. J. Exp. Med. 191:2000;625-630.
39. Zarour H.M., Storkus W.J., Brusic V., Williams E., Kirkwood J.M. Cancer Res. 60:2000;4946-4952.
40. Touloukian C.E.et al. J. Immunol. 164:2000;3535-3542.